308 related articles for article (PubMed ID: 28746769)
21. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
[TBL] [Abstract][Full Text] [Related]
23. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
[TBL] [Abstract][Full Text] [Related]
24. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
[No Abstract] [Full Text] [Related]
25. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
[TBL] [Abstract][Full Text] [Related]
26. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
Pan YJ; Wei LL; Wu XJ; Huo FC; Mou J; Pei DS
Cell Death Dis; 2017 Oct; 8(10):e3155. PubMed ID: 29072688
[TBL] [Abstract][Full Text] [Related]
27. Role of miR-486-5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF-β-activated kinase 1.
He Y; Liu J; Wang Y; Zhu X; Fan Z; Li C; Yin H; Liu Y
J Cell Biochem; 2019 Mar; 120(3):2954-2963. PubMed ID: 30537206
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
29. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
31. The long noncoding RNA EMBP1 inhibits the tumor suppressor miR-9-5p and promotes renal cell carcinoma tumorigenesis.
Hong Y; Yuan Z; Huang R; Wu Z; Li Y
Nefrologia (Engl Ed); 2020; 40(4):429-439. PubMed ID: 32482375
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
Zhang WB; Pan ZQ; Yang QS; Zheng XM
Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor roles of both strands of the
Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Oncotarget; 2018 Jun; 9(42):26638-26658. PubMed ID: 29928475
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
[TBL] [Abstract][Full Text] [Related]
35. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
36. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
38. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
[TBL] [Abstract][Full Text] [Related]
39. MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients.
Lukamowicz-Rajska M; Mittmann C; Prummer M; Zhong Q; Bedke J; Hennenlotter J; Stenzl A; Mischo A; Bihr S; Schmidinger M; Vogl U; Blume I; Karlo C; Schraml P; Moch H
Oncotarget; 2016 Nov; 7(48):78433-78447. PubMed ID: 27738339
[TBL] [Abstract][Full Text] [Related]
40. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
